Lv57
996 积分 2023-08-03 加入
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study
20天前
已完结
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
24天前
已完结
Cellular phenotyping of chronic rhinosinusitis with nasal polyps
1个月前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
New Concepts in Barrier Dysfunction in CRSwNP and Emerging Roles of Tezepelumab and Dupilumab
2个月前
已完结
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP
2个月前
已完结
Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps
2个月前
已完结
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
2个月前
已完结
Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis
2个月前
已完结
Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis
2个月前
已完结
皖公网安备34019202002308
